Evidence map›Paper›PMID 32019627›Full record

ArticleThe British journal of nutrition2020

One-carbon metabolites, B vitamins and associations with systemic inflammation and angiogenesis biomarkers among colorectal cancer patients: results from the ColoCare Study.

Rama Kiblawi, Andreana N Holowatyj, Biljana Gigic, Stefanie Brezina, Anne J M R Geijsen, Jennifer Ose, Tengda Lin, Sheetal Hardikar, Caroline Himbert, Christy A Warby and 17 more

Registry-linked trialOpen access · bronzeAbstract readMulticenter Study
In one paragraph

Article in The British journal of nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02328677 (ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02328677 recruitingnot on this map

ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis

TypeobservationalSponsorUniversity of UtahRan2007 to 2030Enrolled5,000ConditionsColorectal Cancer
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Observational
  4. Article
  5. Review
  6. Article
  7. Article
  8. Associations of Individual and Combined Physical Activity and Body Mass Index Groups with Proinflammatory Biomarkers among Colorectal Cancer Patients.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  9. Article
  10. Article
  11. Presurgery Adhesion Molecules and Angiogenesis Biomarkers Are Differently Associated with Outcomes in Colon and Rectal Cancer: Results from the ColoCare Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 8 institutions in 5 countries.

Rama KiblawiDivision of Cancer Control and Population Sciences, Huntsman Cancer Institute, Salt Lake City, UT, USA.ORCID 0000-0002-6887-5730
Andreana N HolowatyjDivision of Cancer Control and Population Sciences, Huntsman Cancer Institute, Salt Lake City, UT, USA.ORCID 0000-0001-8001-8793
Biljana GigicDepartment of General, Visceral and Transplantation Surgery, University Hospital of Heidelberg, Germany.
Stefanie BrezinaDepartment of Medicine I, Institute of Cancer Research, Medical University of Vienna, Austria.
Anne J M R GeijsenDivision of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands.
Jennifer OseDivision of Cancer Control and Population Sciences, Huntsman Cancer Institute, Salt Lake City, UT, USA.
Tengda LinDivision of Cancer Control and Population Sciences, Huntsman Cancer Institute, Salt Lake City, UT, USA.
Sheetal HardikarDivision of Cancer Control and Population Sciences, Huntsman Cancer Institute, Salt Lake City, UT, USA.
Caroline HimbertDivision of Cancer Control and Population Sciences, Huntsman Cancer Institute, Salt Lake City, UT, USA.
Christy A WarbyDivision of Cancer Control and Population Sciences, Huntsman Cancer Institute, Salt Lake City, UT, USA.
Jürgen BöhmDivision of Cancer Control and Population Sciences, Huntsman Cancer Institute, Salt Lake City, UT, USA.
Martijn J L BoursDepartment of Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.
Fränzel J B van DuijnhovenDivision of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands.
Tanja GumpenbergerDepartment of Medicine I, Institute of Cancer Research, Medical University of Vienna, Austria.
Dieuwertje E KokDivision of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands.
Janna L KooleDepartment of Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.
Eline H van RoekelDepartment of Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.
Petra Schrotz-KingDivision of Preventive Oncology, German Cancer Research Center and National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany.
Arve UlvikBevital A/S, Bergen, Norway.
Andrea GsurDepartment of Medicine I, Institute of Cancer Research, Medical University of Vienna, Austria.
Nina HabermannDepartment of Genome Biology, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.
Matty P WeijenbergDepartment of Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.
Per Magne UelandBevital A/S, Bergen, Norway.
Martin SchneiderDepartment of General, Visceral and Transplantation Surgery, University Hospital of Heidelberg, Germany.
Alexis UlrichDepartment of General, Visceral and Transplantation Surgery, University Hospital of Heidelberg, Germany.
Cornelia M Ulrich *Division of Cancer Control and Population Sciences, Huntsman Cancer Institute, Salt Lake City, UT, USA.
Mary Playdon *Division of Cancer Control and Population Sciences, Huntsman Cancer Institute, Salt Lake City, UT, USA.ORCID 0000-0001-6082-0447
University of Utah · USMaastricht University · NLHeidelberg University · DEMedical University of Vienna · ATWageningen University & Research · NLBevital (Norway) · NOEuropean Molecular Biology Laboratory · DEGerman Cancer Research Center · DE

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI KATHARINE S ULLMAN · 1986 to 2026
$72.6M
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare StudyU01CA206110 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jane C. Figueiredo, Christopher I Li · 2016 to 2026
$18.6M
Discovery and verification of novel biomarkers of colorectal cancer recurrenceR01CA189184 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI LI, CHRISTOPHER I, ULRICH, CORNELIA M · 2015 to 2020
$5.6M
Metabolomic Strategies for Discovery and Validation of Biomarkers of Colorectal Cancer RecurrenceR01CA207371 · NCI · UNIVERSITY OF UTAH · PI LI, CHRISTOPHER I, ULRICH, CORNELIA M · 2017 to 2022
$3.9M
Training Program in Genomic MedicineT32HG008962 · NHGRI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Lynn Jorde, Aaron R Quinlan · 2016 to 2026
$3.0M
Diabetes, Medications and the Cost-Effectiveness of Screening for Colorectal NeoplasiaK07CA222060 · NCI · UNIVERSITY OF UTAH · PI HARDIKAR, SHEETAL · 2018 to 2022
$791k
Blood metabolite profiles and risk of developing endometrial cancerR00CA218694 · NCI · UNIVERSITY OF UTAH · PI PLAYDON, MARY CHRISTINE · 2018 to 2020
$747k
Austrian Science Fund FWF I 2104NCI NIH HHS K07 CA222060NCI NIH HHS P30 CA042014NCI NIH HHS R00 CA218694NCI NIH HHS R01 CA189184NCI NIH HHS R01 CA207371NCI NIH HHS U01 CA206110NHGRI NIH HHS T32 HG008962
6 · The paper itself

Abstract

B vitamins involved in one-carbon metabolism have been implicated in the development of inflammation- and angiogenesis-related chronic diseases, such as colorectal cancer (CRC). Yet, the role of one-carbon metabolism in inflammation and angiogenesis among CRC patients remains unclear. The objective of this study was to investigate associations of components of one-carbon metabolism with inflammation and angiogenesis biomarkers among newly diagnosed CRC patients (n 238) in the prospective ColoCare Study, Heidelberg. We cross-sectionally analysed associations between twelve B vitamins and one-carbon metabolites and ten inflammation and angiogenesis biomarkers from pre-surgery serum samples using multivariable linear regression models. We further explored associations among novel biomarkers in these pathways with Spearman partial correlation analyses. We hypothesised that pyridoxal-5'-phosphate (PLP) is inversely associated with inflammatory biomarkers. We observed that PLP was inversely associated with C-reactive protein (CRP) (r -0·33, Plinear < 0·0001), serum amyloid A (SAA) (r -0·23, Plinear = 0·003), IL-6 (r -0·39, Plinear < 0·0001), IL-8 (r -0·20, Plinear = 0·02) and TNFα (r -0·12, Plinear = 0·045). Similar findings were observed for 5-methyl-tetrahydrofolate and CRP (r -0·14), SAA (r -0·14) and TNFα (r -0·15) among CRC patients. Folate catabolite acetyl-para-aminobenzoylglutamic acid (pABG) was positively correlated with IL-6 (r 0·27, Plinear < 0·0001), and pABG was positively correlated with IL-8 (r 0·21, Plinear < 0·0001), indicating higher folate utilisation during inflammation. Our data support the hypothesis of inverse associations between PLP and inflammatory biomarkers among CRC patients. A better understanding of the role and inter-relation of PLP and other one-carbon metabolites with inflammatory processes among colorectal carcinogenesis and prognosis could identify targets for future dietary guidance for CRC patients.

Indexed as

AdolescentAdultAgedAged, 80 and overAmyloidBiomarkers, TumorCarbonColorectal NeoplasmsC-Reactive ProteinCross-Sectional StudiesFemaleFolic AcidGlutamatesHumansInflammationInflammation Mediators4-aminobenzoylglutamic acid5-methyltetrahydrofolateAmyloidBiomarkers, TumorCarbonC-Reactive ProteinFolic AcidGlutamatesInflammation MediatorsInterleukin-6Interleukin-8Phosphoric Monoester Hydrolasespyridoxal-5-phosphataseTetrahydrofolatesTumor Necrosis Factor-alphaVitamin B ComplexAngiogenesisB vitaminsColorectal cancerFolateInflammationOne-carbon metabolismVitamin B6

Identifiers

PMID32019627
PMCPMC7425811
OpenAlexW3005161933

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.